Dr. Clinton Allen King , MD
Dermatology • El Paso, TX
10657 Vista Del Sol, Suite A
El Paso, TX 799354504
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on December 11, 2006; this date does not establish years in practice.
-
Published CMS data list 550 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- 99212 — Established patient outpatient office visit: 190 service units.
- 17003 — Destruction of precancer skin growth, 2-14 growths: 98 service units.
- 99213 — Established patient outpatient office visit: 82 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPT® only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 8 records in the table · Guide: How to read Medicare Part B data
-
Published CMS data list 208 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Mupirocin — 48 prescription fills, including refills.
- Tretinoin — 33 prescription fills, including refills.
- Betamethasone Dipropionate — 27 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 8 records in the table · Guide: How to read Medicare Part D prescriber data
-
Fewer Medicare Part B services than 85% of clinicians listed under Dermatology in Texas (2024, 830 clinicians with data). Median for this group: 2,197. Middle half: 1,083 to 4,729.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 723 in 2020 to 550 in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2020–2024.
Practice Location & Contact Primary Location
10657 Vista Del Sol
Suite A
El Paso, TX 799354504
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026
Meharry Medical College School Of Medicine
1973
What Public CMS Data Show
Dermatology: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
199 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.
Medicare-allowed amount
About $30,503 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
Paid by Medicare
About $21,882 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
30-day fills
210 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$5,395 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $258.63 across 26 records.
By nature of payment
- Food and Beverage: $258.63 across 26 records.
Reporting-company totals
- Incyte Corporation: $230.83 across 25 records.
- SUN PHARMACEUTICAL INDUSTRIES INC.: $27.80 across 1 record.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
53 years (graduated 1973)
CMS Doctors and Clinicians data list 1973 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026.
NPI first issued
2006
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
May accept Medicare assignment
CMS data show this clinician may accept Medicare assignment. Clinicians who do not always accept assignment can decide case by case.
Ask the office before your visit. If a clinician does not accept assignment for a service, they can charge up to 15% more than the Medicare-approved amount, and you may be asked to pay the full amount at the visit.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians, CMS release of October 2, 2026; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians, CMS release of October 2, 2026.
Enrolled in Medicare (PECOS)
Dr. King has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. King as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in El Paso and Texas
Billing and prescribing volume is not a quality rating.
Medicare Part B services
Fewer Medicare Part B services than 85% of clinicians listed under Dermatology in Texas (2024, 830 clinicians with data). Median for this group: 2,197. Middle half: 1,083 to 4,729.
Too few clinicians listed under Dermatology in El Paso have Medicare Part B data for 2024 to compare.
Medicare-allowed amount
A lower Medicare-allowed amount than 85% of clinicians listed under Dermatology in Texas (2024, 830 clinicians with data). Median for this group: $135,436. Middle half: $65,432 to $291,321.
Too few clinicians listed under Dermatology in El Paso have Medicare Part B data for 2024 to compare.
Paid by Medicare
A lower Medicare payment amount than 85% of clinicians listed under Dermatology in Texas (2024, 830 clinicians with data). Median for this group: $95,793. Middle half: $45,476 to $209,429.
Too few clinicians listed under Dermatology in El Paso have Medicare Part B data for 2024 to compare.
Medicare Part D prescriptions
Fewer Part D prescriptions than 70% of clinicians listed under Dermatology in Texas (2024, 934 clinicians with data). Median for this group: 479. Middle half: 197 to 946.
Too few clinicians listed under Dermatology in El Paso have Medicare Part D data for 2024 to compare.
Part D drug cost
A lower Part D drug cost than 75% of clinicians listed under Dermatology in Texas (2024, 934 clinicians with data). Median for this group: $79,996. Middle half: $6,799 to $221,327.
Too few clinicians listed under Dermatology in El Paso have Medicare Part D data for 2024 to compare.
13 active clinicians are listed under Dermatology with a practice address in El Paso, TX (1,195 in Texas).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in El Paso
0% of these 13 clinicians have the CMS telehealth indicator.
53.8% of these 13 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services decreased 24% from 723 in 2020 to 550 in 2024.
- 2020: 723
- 2021: 688
- 2022: 602
- 2023: 611
- 2024: 550
-
Medicare-allowed amount
Medicare-allowed amount decreased 23% from $39,853 in 2020 to $30,503 in 2024.
- 2020: $39,853
- 2021: $40,896
- 2022: $33,534
- 2023: $35,809
- 2024: $30,503
-
Paid by Medicare
Paid by Medicare decreased 14% from $25,589 in 2020 to $21,882 in 2024.
- 2020: $25,589
- 2021: $29,457
- 2022: $22,740
- 2023: $24,716
- 2024: $21,882
-
Medicare Part D prescriptions
Medicare Part D prescriptions varied from year to year: 226 in 2020 and 208 in 2024.
- 2020: 226
- 2021: 364
- 2022: 321
- 2023: 276
- 2024: 208
-
30-day fills
30-day fills varied from year to year: 228 in 2020 and 210 in 2024.
- 2020: 228
- 2021: 365
- 2022: 326
- 2023: 280
- 2024: 210
-
Part D drug cost
Part D drug cost decreased 26% from $7,287 in 2020 to $5,395 in 2024.
- 2020: $7,287
- 2021: $15,745
- 2022: $12,574
- 2023: $8,559
- 2024: $5,395
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $195.67 in 2021 to $258.63 in 2025.
- 2021: $195.67
- 2022: $279.63
- 2023: $352.67
- 2024: $253.80
- 2025: $258.63
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS release of October 2, 2026, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 26 records totaling $258.63.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. |
Food and Beverage
In-kind items and services
|
Winlevi | General | $27.80 |
| Incyte Corporation |
Food and Beverage
Cash or cash equivalent
|
OPZELURA | General | $15.08 |
| Incyte Corporation |
Food and Beverage
Cash or cash equivalent
|
OPZELURA | General | $14.01 |
| Incyte Corporation |
Food and Beverage
Cash or cash equivalent
|
OPZELURA | General | $13.81 |
| Incyte Corporation |
Food and Beverage
Cash or cash equivalent
|
OPZELURA | General | $13.68 |
| Incyte Corporation |
Food and Beverage
Cash or cash equivalent
|
OPZELURA | General | $11.96 |
| Incyte Corporation |
Food and Beverage
Cash or cash equivalent
|
OPZELURA | General | $11.58 |
| Incyte Corporation |
Food and Beverage
Cash or cash equivalent
|
OPZELURA | General | $11.46 |
| Incyte Corporation |
Food and Beverage
Cash or cash equivalent
|
OPZELURA | General | $11.28 |
| Incyte Corporation |
Food and Beverage
Cash or cash equivalent
|
OPZELURA | General | $10.70 |
| Incyte Corporation |
Food and Beverage
Cash or cash equivalent
|
OPZELURA | General | $10.39 |
| Incyte Corporation |
Food and Beverage
Cash or cash equivalent
|
OPZELURA | General | $10.28 |
| Incyte Corporation |
Food and Beverage
Cash or cash equivalent
|
OPZELURA | General | $9.78 |
| Incyte Corporation |
Food and Beverage
Cash or cash equivalent
|
OPZELURA | General | $9.39 |
| Incyte Corporation |
Food and Beverage
Cash or cash equivalent
|
OPZELURA | General | $8.82 |
| Incyte Corporation |
Food and Beverage
Cash or cash equivalent
|
OPZELURA | General | $8.48 |
| Incyte Corporation |
Food and Beverage
Cash or cash equivalent
|
OPZELURA | General | $7.97 |
| Incyte Corporation |
Food and Beverage
Cash or cash equivalent
|
OPZELURA | General | $7.74 |
| Incyte Corporation |
Food and Beverage
Cash or cash equivalent
|
OPZELURA | General | $7.16 |
| Incyte Corporation |
Food and Beverage
Cash or cash equivalent
|
OPZELURA | General | $7.12 |
| Incyte Corporation |
Food and Beverage
Cash or cash equivalent
|
OPZELURA | General | $6.04 |
| Incyte Corporation |
Food and Beverage
Cash or cash equivalent
|
OPZELURA | General | $5.80 |
| Incyte Corporation |
Food and Beverage
Cash or cash equivalent
|
OPZELURA | General | $5.79 |
| Incyte Corporation |
Food and Beverage
Cash or cash equivalent
|
OPZELURA | General | $5.63 |
| Incyte Corporation |
Food and Beverage
Cash or cash equivalent
|
OPZELURA | General | $4.11 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
99212
Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more
|
190 | 110 | $58.82 | $51.09 |
|
17003
Destruction of precancer skin growth, 2-14 growths
|
98 | 39 | $6.70 | $5.82 |
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
82 | 71 | $94.81 | $82.27 |
|
17000
Destruction of precancer skin growth, 1 growth
|
79 | 71 | $68.84 | $59.80 |
|
17110
Destruction of skin growth, 1-14 growths
|
39 | 34 | $117.82 | $101.70 |
|
99202
New patient office or other outpatient visit with straightforward medical decision making, if using time, 15 minutes or more
|
36 | 36 | $75.20 | $65.42 |
|
99203
New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
|
15 | 15 | $113.58 | $99.44 |
|
11102
Biopsy of related skin growth, first growth
|
11 | 11 | $98.66 | $85.66 |
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Mupirocin | Mupirocin | 48 | 665 | $375.35 | 40 |
| Tretinoin | Tretinoin | 33 | 815 | $1,236.40 | 24 |
| Betamethasone Dipropionate | Betamethasone Dipropionate | 27 | 427 | $752.33 | 21 |
| Fluticasone Propionate | Fluticasone Propionate | 25 | 382 | $394.91 | 20 |
| Ketoconazole | Ketoconazole | 25 | 530 | $325.28 | 12 |
| Mometasone Furoate | Mometasone Furoate | 19 | 359 | $314.33 | 15 |
| Clobetasol Propionate | Clobetasol Propionate | 18 | 417 | $1,465.35 | 13 |
| Minocycline Hcl | Minocycline Hcl | 13 | 390 | $531.00 | — |
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
NUCC Taxonomy Code: 207N00000X
A dermatologist is trained to diagnose and treat pediatric and adult patients with benign and malignant disorders of the skin, mouth, external genitalia, hair and nails, as well as a number of sexually transmitted diseases. The dermatologist has had additional training and experience in the diagnosis and treatment of skin cancers, melanomas, moles and other tumors of the skin, the management of contact dermatitis and other allergic and nonallergic skin disorders, and in the recognition of the skin manifestations of systemic (including internal malignancy) and infectious diseases. Dermatologists have special training in dermatopathology and in the surgical techniques used in dermatology. They also have expertise in the management of cosmetic disorders of the skin such as hair loss and scars and the skin changes associated with aging.
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - DERMATOLOGY
I20110525000242
TX
5597941617
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Career & Practice History
NPI enumerated December 11, 2006.
No changes to the name, practice address, taxonomy or NPI status in this record have been observed in the monthly NPPES data files from January 2017 to November 2026.
NPI Administrative Meta
Other Dermatology Specialists in El Paso
- Dr. Peter Herman, MD
- Dr. Mitchell Davis, MD
- Dr. Eugene Brooks, MD
- Dr. Richard Vinson, MD
- Dr. Samuel Almquist, MD
- Dr. Adrian Guevara, MD
Mailing Address
10657 Vista Del Sol, Suite A
El Paso, TX 799354504
Phone: 9155983943